COMMUNIQUÉS West-GlobeNewswire

Candel Therapeutics Completes $28.7 Million Series B Financing

04/01/2019 - 20:33

Proceeds to Accelerate Enrollment of Phase 3 Localized Prostate Cancer Clinical Trial and to Advance Late Stage High-Grade Glioma Clinical Program Candel to Expand Clinical Trials in Other Indications AUBURNDALE, Mass [...]

Stryker to host conference call on January 29, 2019

04/01/2019 - 20:30

Kalamazoo, Michigan, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results [...]

VALNEVA : Bilan Semestriel du contrat de liquidité de Valneva SE

04/01/2019 - 18:00

Paris, le 4 janvier 2019 Bilan semestriel du contrat de liquidité VALNEVA contracté avec ODDO & Cie Au titre du contrat de liquidité confié à Oddo Corporate Finance portant sur les actions de la société VALNEVA, à [...]

Spineway: Subscription of 2nd tranche of 100 bonds for a par value of €1M as per the Additional Commitment

04/01/2019 - 18:00

Spineway Subscription of 2nd tranche of 100 bonds convertible into new and/or existing shares ( OCEANE ) with attached warrants for a par value of €1M as per the Additional Commitment. Spineway (the “ Company ”) [...]

Spineway: Souscription de la 2ème tranche de 100 obligations pour un montant nominal d’1 MEUR au titre de l’Engagement Complémentaires

04/01/2019 - 18:00

SPINEWAY Souscription de la 2ème tranche de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d’actions pour un montant nominal d’1 MEUR au [...]

111, Inc. Signs Online Healthcare Project Strategic Framework Agreement with the Kunshan Health Commission

04/01/2019 - 17:21

SHANGHAI, Jan. 04, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online-offline healthcare platform, announced today the signing of a strategic framework agreement with [...]

GeneSight® GUIDED Study Published in the Journal of Psychiatric Research

04/01/2019 - 16:02

Large, Blinded Prospective Study Demonstrates that GeneSight Improves Clinical Outcomes in Patients with Treatment Resistant Major Depressive Disorder SALT LAKE CITY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, [...]

Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research

04/01/2019 - 16:00

Results Demonstrate an Increased Survival Rate for Patients Treated with Epicel CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports [...]

Indiana Minority Health Coalition in Partnership to Host Second Statewide Town Hall Meeting on Infant Mortality in the Black Community

04/01/2019 - 15:55

Co-Sponsors Include Side Effects Media and the Indianapolis Recorder INDIANAPOLIS, Jan. 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Minority Health Coalition (IMHC) in partnership with Side Effects Media and the [...]

Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events

04/01/2019 - 15:15

Company to Release New Survey Findings from C-Suite Leaders on Commercial Spend and Planning and Essentials for a Successful Launch MORRISVILLE, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the [...]

Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System

04/01/2019 - 15:13

ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 woman in the BLOC [...]

OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands

04/01/2019 - 15:00

WARSAW, Ind., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today their recently [...]

HMS Hires Robert P. Borchert as New Investor Relations Officer

04/01/2019 - 15:00

IRVING, Texas, Jan. 04, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp (Nasdaq:HMSY) today announced that Robert P. Borchert has joined the Company as Senior Vice President, Investor Relations. He succeeds Dennis Oakes, who [...]

Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 15:00

Industry’s Largest Symposium Brings Over 9,000 Attendees to San Francisco CHARLOTTESVILLE, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company [...]

La Jolla Pharmaceutical Company to Present at the 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 15:00

SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 14:30

Heidelberg, Germany, January 4, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to improving patient outcomes through the power of the innate immune system, today announced that [...]

Tauriga Sciences Inc. Reveals Several of the Specific & Differentiating Features Integrated into its Cannabis/CBD Infused Chewing Gum Product Line

04/01/2019 - 14:30

New York, NY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

04/01/2019 - 14:30

DTX401 Response Observed in All Three Patients, with Two Patients Demonstrating Clinically Meaningful Improvement in Time to Hypoglycemia Study to Advance to Cohort 2 at a Higher Dose NOVATO, Calif., Jan. 04, 2019 ( [...]

Resonant Inc. to Present at the 21st Annual Needham Growth Conference

04/01/2019 - 13:05

GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]